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Insulin secretion is essential for maintenance of
glucose homeostasis, but the mechanism of insulin
granule exocytosis, the final step of insulin secretion,
is largely unknown. Here, we investigated the role of
Rim2a in insulin granule exocytosis, including the
docking, priming, and fusion steps. We found that
interaction of Rim2a and Rab3A is required for dock-
ing,which is consideredabrakeon fusion events, and
that docking is necessary for K+-induced exocytosis,
but not for glucose-induced exocytosis. Further-
more, we found that dissociation of the Rim2a/
Munc13-1 complex by glucose stimulation activates
Syntaxin1byMunc13-1, indicating thatRim2aprimes
insulin granules for fusion. Thus, Rim2a determines
docking and priming states in insulin granule exocy-
tosis depending on its interacting partner, Rab3A
or Munc13-1, respectively. Because Rim2a/ mice
exhibit impaired secretion of various hormones
stored as dense-core granules, including glucose-
dependent insulinotropic polypeptide, growth
hormone, and epinephrine, Rim2a plays a critical role
in exocytosis of these dense-core granules.
INTRODUCTION
Stimulus-secretion coupling has been characterized in neurons
and neuroendocrine and endocrine cells (Burgoyne andMorgan,
2003; Sudhof, 2004; Seino and Shibasaki, 2005). Pancreatic
b cells, in which insulin is stored as dense-core granules, play
a central role in glucose homeostasis. Although understanding
of the molecular mechanisms of cell signaling in insulin secretion
has deepened remarkably in recent years, the mechanisms of
insulin granule exocytosis, the final step in the insulin secretory
process, are largely unknown.CelRecently, various molecules interacting with the insulin
granules have been identified (Brunner et al., 2007), including
Rab27A (Kasai et al., 2005), granuphilin (Gomi et al., 2005),
ZnT8 (Nicolson et al., 2009), Noc2 (Matsumoto et al., 2004),
collectrin (Fukui et al., 2005), and Rap1 (Shibasaki et al., 2007).
Mutation of the Rab27A gene was discovered from Griscelli
syndrome in human, characterized by hypopigmentation and
loss of cytotoxic killing activity by cytotoxic T lymphocytes
(Me´nasche´ et al., 2000). The same mutation found in the mouse
coat-color mutant ashen causes a defect in insulin granule
exocytosis (Kasai et al., 2005). Granuphilin/ mice, ZnT8/
mice, Noc2/ mice, and transgenic mice overexpressing
collectrin also exhibit impaired insulin secretion and abnormal
glucose homeostasis.
We previously identified Rab3-interacting molecule 2 (Rim2)
by yeast two-hybrid screen of a clonal pancreatic b cell (MIN6)
cDNA library (Ozaki et al., 2000). Rim2 is now known as a
multidomain protein that occurs as three variants, including
Rim2a, Rim2b, and Rim2g (Wang and Su¨dhof, 2003). Rim2a,
the full-length form of Rim2, is composed of an N-terminal
Zn2+-finger domain, a central PDZ and C2A domains, and a
C-terminal C2B domain. Rim2b lacks the N-terminal Zn
2+-finger
domain of Rim2a, whereas Rim2g is composed only of the
C-terminal C2B domain of Rim2a with flanking sequences.
Rim2a interacts with Rab3A (Ozaki et al., 2000), Munc13-1
(Dulubova et al., 2005), and Rab8 (Fukuda, 2003) at the
N-terminal region. In addition to interaction with these proteins,
Rim2a binds to cAMP-GEFII (also referred to as Epac2) (Ozaki
et al., 2000; Shibasaki et al., 2004) and ELKS (Ohara-Imaizumi
et al., 2005; Inoue et al., 2006) through the central PDZ domain,
to Piccolo through a C2A domain (Fujimoto et al., 2002), to
RIM-BPs through a PXXP sequence between the two C2
domains (Hibino et al., 2002), and to Liprin-a1 and synaptotag-
min 1 through the C-terminal C2B domain (Schoch et al.,
2002). These findings suggest that Rim2a functions as a scaffold
protein and that it is involved in regulated exocytosis. Indeed,
Rim2a has been found to be involved in cAMP-potentiated
insulin secretion through the Epac2 pathway in in vitro studies
(Ozaki et al., 2000; Kashima et al., 2001). Although Rim2a isl Metabolism 12, 117–129, August 4, 2010 ª2010 Elsevier Inc. 117
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Role of Rim2a in Insulin Granule Exocytosisexpressedmainly in endocrine and neuroendocrine cells such as
pancreatic b cells, pituitary, and adrenal gland, it is unknown how
Rim2a acts in the steps in the process of exocytosis, including
recruitment, docking, priming, and fusion.
Rim1a, an isoform of Rim2a, is expressed mainly in brain and
a putative Rab3 effector involved in the regulation of synaptic
vesicle fusion (Wang et al., 1997). Studies of Rim1a/ mice
(Castillo et al., 2002; Lonart et al., 2003) and the null mutation
of Rim in C. elegans (Koushika et al., 2001) indicate that Rim1a
is important for long-term potentiation by increasing neurotrans-
mitter release at mossy fiber synapses in the CA3 region in
hippocampus of cerebrumand that it is involved in a postdocking
step. To clarify the role of Rim2a in endocrine function both
in vitro and in vivo, we generated Rim2a/ mice. In the course
of our study, Schoch et al. also generated Rim2a/ mice and
reported the phenotype of the mice (Schoch et al., 2006).
They found no apparent developmental abnormalities of these
mice, but there were slight behavioral differences and slightly
lower survival rates compared toRim2a+/+mice. They also found
no changes in body fat content or blood glucose levels in
Rim2a/ mice. However, no study of endocrine or neuroendo-
crine functions in Rim2a/ mice was reported.
In the present study, we show that Rim2a is required for the
docking and priming states in insulin granule exocytosis through
interaction with Rab3A and Munc13-1, respectively, and that,
although docking is necessary for K+-induced exocytosis, it is
unnecessary for glucose-induced exocytosis. In addition, we
found secretory defects in various hormones, including
glucose-dependent insulinotropic polypeptide (GIP), growth
hormone (GH), and epinephrine in Rim2a/ mice in vivo. Thus,
Rim2a is a key molecule in insulin granule exocytosis and also
is required in normal secretion of hormones associated with
glucose homeostasis.
RESULTS
Insulin andGIP Secretion Are Impaired inRim2a/Mice
In Vivo
The Rim2 gene has three independent promoters that create
three variant forms of Rim2, Rim2a, Rim2b, and Rim2g (Wang
and Su¨dhof, 2003) (Figure S1A available online). We found that,
among the three variants, Rim2a is predominantly expressed in
pancreatic islets and insulin-secreting MIN6 cells (Figure S1B
and S1C). We generated Rim2a/ mice in which the fourth
exon of the Rim2 gene was replaced by Neo cassette (Fig-
ure S1D). The absence of Rim2a expression in Rim2a/ mice
was confirmed by northern blot analysis, reverse transcription
PCR, and immunoblot analysis (Figures S1E–S1G). The expres-
sion levels of Rim2b and Rim2g were not changed in Rim2a/
mice (Figure S1H). Rim2a/ mice were viable and fertile.
Rim2a/ mice exhibited islet hyperplasia (Rim2a+/+ = 7,887.6 ±
728.1 mm2; Rim2a/ = 15,620.4 ± 1,486.7 mm2; n = 4 and
100 islets; p < 0.01) and a relatively increased number of a cells
(Rim2a+/+ = 14.7% ± 1.5% of islets; Rim2a/ = 40.0% ± 2.5%
of islets; p < 0.01; n = 3, n = 53 for Rim2a+/+ and n = 37 for
Rim2a/) (Figure S1I).
We performed intraperitoneal glucose tolerance test (IPGTT)
to examine pancreatic endocrine function in Rim2a/ mice.
The fasting blood glucose levels of Rim2a/ mice were118 Cell Metabolism 12, 117–129, August 4, 2010 ª2010 Elsevier Incsignificantly decreased compared those of Rim2a+/+ mice
(Rim2a+/+ = 119 ± 3.1 mg/dl; Rim2a/ = 87 ± 4.7 mg/dl;
p < 0.01; n = 19 for Rim2a+/+ and n = 17 for Rim2a/). The blood
glucose levels of Rim2a/ mice 60 min after intraperitoneal
glucose administration were significantly higher than those of
Rim2a+/+ mice. The insulin response during IPGTT in Rim2a/
mice was markedly lower than that in Rim2a+/+ mice
(Figure 1A). We also examined changes in blood glucose and
insulin levels after oral glucose administration (OGTT). The blood
glucose levels of Rim2a/ mice during OGTT were significantly
higher than those of Rim2a+/+ mice at all time points examined.
The insulin levels were markedly reduced in Rim2a/ mice
compared to those in Rim2a+/+ mice (Figure 1B). Similar results
were obtained by oral mixed meal administration (Figure 1C).
These results suggest that incretin secretion is decreased in
Rim2a/ mice. GIP, an incretin secreted by enteroendocrine
cells in response to ingestion of nutrients, potentiates glucose-
induced insulin secretion (Drucker, 2006). To investigate the
possible involvement of incretins in this reduced insulin secre-
tion, we attempted to measure the serum levels of GIP and
glucagon-like peptide-1 (GLP-1) in Rim2a/ mice. Although
GIP-secreting K cells were present in Rim2a/ mice (Fig-
ure S1J), serum GIP levels in Rim2a/ mice were below the
sensitivity of assay (Figure 1D). However, the measurement of
GLP-1, another incretin, in mouse serum was not possible by
using commercially available kits despite several attempts.
These results indicate that both insulin and GIP secretion in
Rim2a/ mice are markedly impaired.
Insulin Secretion Is Impaired in Pancreatic Islets
of Rim2a/ Mice
As shown in Figure 2A, insulin content of the islets of Rim2a/
mice was increased 1.4-fold, compared to that of Rim2a+/+
mice. Both glucose-induced and Ca2+-triggered insulin secre-
tion (assessed by 60 mM K+ stimulation) from pancreatic islets
of Rim2a/ mice were significantly decreased, compared to
those from pancreatic islets of Rim2a+/+ mice (Figure 2B). We
then examined insulin secretion potentiated by cAMP in pancre-
atic islets of Rim2a/ mice. GIP-potentiated insulin secretion
from pancreatic islets of Rim2a/ mice was significantly lower
than that of Rim2a+/+ mice (Figure 2C). The cAMP analog
8-Bromo-cAMP-potentiated insulin secretion also was signifi-
cantly reduced in pancreatic islets of Rim2a/ mice. These
results strongly suggest that Rim2a plays a major role in insulin
secretion.
The Number of Docked Insulin Granules Is Decreased
in Pancreatic b Cells of Rim2a/ Mice
We investigated the role of Rim2a in insulin granule exocytosis.
For this purpose, we analyzed the dynamics of insulin granules
in living pancreatic b cells using total internal reflection fluores-
cence microscopy (TIRFM) (Shibasaki et al., 2007). We con-
firmed that the modes of insulin granule exocytosis can be
classified into three groups depending on the dynamics of the
insulin granules: (1) fusion events involving granules that are
predocked to the plasma membrane (old face); (2) fusion events
involving granules that are newly recruited and immediately
fused to the plasma membrane without docking (restless
newcomer); and (3) fusion events involving granules that are.
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Figure 1. Impaired Insulin and GIP Secretion in Rim2a/ Mice
(A) Changes in blood glucose levels (left) and serum insulin levels (right) after intraperitoneal glucose load in Rim2a+/+ mice (white) and Rim2a/ mice (black).
(B) Changes in blood glucose levels (left) and serum insulin levels (right) after oral glucose load in Rim2a+/+ mice (white) and Rim2a/ mice (black).
(C) Changes in blood glucose levels (left) and serum insulin levels (right) after mixed meal load in Rim2a+/+ mice (white) and Rim2a/ mice (black).
(D) GIP secretion after mixed meal load in Rim2a+/+ mice (white) and Rim2a/ mice (black).
Data were obtained from three independent experiments (n = 5–19) and expressed as means ± SEM. *p < 0.01 (Student’s unpaired t test).
See also Figure S1.
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Role of Rim2a in Insulin Granule Exocytosisnewly recruited, docked, and then fused to the plasma
membrane (resting newcomer).
As shown in Figure 3A, the number of docked insulin granules
in pancreatic b cells of Rim2a/mice was markedly decreased,
compared to that in pancreatic b cells ofRim2a+/+mice.We have
previously shown that most K+-induced fusion events involve old
face (Shibasaki et al., 2007). As expected, the number of fusion
events caused by K+ stimulation in pancreatic b cells of
Rim2a/ mice was significantly decreased due to the marked
reduction in the number of old face (Figure 3B). In contrast,
glucose-induced fusion events comprised mainly restless
newcomer. Fusion events, mainly in the first phase, were mark-
edly decreased in pancreatic b cells ofRim2a/mice, and those
in the second phase were also decreased (Figure 3C). Resting
newcomer, which docks to the plasma membrane before fusion,
were not detected in pancreatic b cells of Rim2a/mice. These
results indicate that Rim2a is required in normal regulation of
insulin granule exocytosis.
The Defect in Insulin Granule Exocytosis in Rim2a/
Mice Is Not Due to Changes in Expression
or Distribution of Exocytosis-Associated Proteins
We intended to examine the expression and subcellular localiza-
tion of exocytosis-associated proteins as a consequence of
Rim2a deficiency, using pancreatic b cells of Rim2a/ mice.
However, the limited number of isolated pancreatic b cells ofCelthese mice made such an experiment impossible. We therefore
established clonal pancreatic b cells lacking Rim2a (Rim2ako/ko
b cells) by crossbreeding Rim2a/ mice and IT6 mice express-
ing simian virus 40 large T antigen under human insulin promoter
(Miyazaki et al., 1990). The absence of Rim2a expression in
Rim2ako/ko b cells was confirmed by immunocytochemical
and immunoblot analyses using anti-Rim2 antibody (Figures 4A
and 4B).
To determine whether deficiency of Rim2a affects the
expression levels and localization of exocytosis-associated
proteins, we compared those of the proteins in MIN6 cells and
Rim2ako/ko b cells. We found no significant differences in the
expression levels of any of the proteins examined (Figure 4B).
The expression levels did not differ in Rim2ako/ko b cells express-
ing wild-type (WT) Rim2a by adenovirus-mediated gene transfer.
We examined localization of Rim2a and exocytosis-associated
proteins in MIN6 cells by immunostaining and subcellular
fractionation experiments. Rim2a was localized on both insulin
granules and plasma membrane (Figures 4A and 4C), whereas
Rab3A, Munc13-1, and Syntaxin1 were localized on the plasma
membrane (Figure 4C). The localizations of these proteins were
the same in Rim2ako/ko b cells.
We then examined insulin secretion in Rim2ako/ko b cells.
Both glucose- and K+-induced insulin secretion from Rim2ako/ko
b cells were significantly reduced, compared to those from
MIN6 cells (Figure 4D). Similarly to the pancreatic b cells ofl Metabolism 12, 117–129, August 4, 2010 ª2010 Elsevier Inc. 119
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Figure 2. Impaired Insulin Secretion in Pancreatic Islets of Rim2a/
Mice
(A) Insulin contents in pancreatic islets of Rim2a+/+ mice (white) and Rim2a/
mice (black).
(B) Insulin secretion in response to glucose and 60 mM K+ in pancreatic islets
of Rim2a+/+ mice (white) and Rim2a/ mice (black).
(C) Effects of cAMP-increasing agents on insulin secretion in pancreatic islets
of Rim2a+/+ mice (white) and Rim2a/ mice (black).
Data were obtained from two to three independent experiments (n = 5–9) and
expressed as means ± SEM. *p < 0.01 (Student’s unpaired t test).
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Role of Rim2a in Insulin Granule ExocytosisRim2a/ mice, the number of docked insulin granules was
significantly decreased in Rim2ako/ko b cells (Figure 4E). Impor-
tantly, the defects in both insulin secretion and the number of
docked insulin granules were rescued when WT Rim2a was120 Cell Metabolism 12, 117–129, August 4, 2010 ª2010 Elsevier Incexogenously introduced by adenovirus-based gene transfer
(Figures 4D and 4E). These results indicate that Rim2a is required
for the docking step in insulin granule exocytosis.
Rim2a, Rab3A, and Munc13-1 Form a Complex
Regulated by Glucose
Because the expression levels and localization of exocytosis-
associated proteins inRim2ako/ko b cells did not differ from those
in MIN6 cells, we explored the possibility that the interaction of
Rim2a and Rim2a-binding proteins is critical for regulated
exocytosis of insulin granules. We performed immunoprecipita-
tion experiments on the interaction of Rim2a with Rab3A or
Munc13-1 by glucose stimulation. The interaction of Rim2a
andMunc13-1wasdecreasedbyglucose stimulation (Figures 4F
and S2). However, no interaction of Rim2a and endogenous
Rab3A was detected (Figure 4F). This suggests that most of
the endogenous Rab3A is likely to be in the GDP-inactivated
state because Rim2a binds to the GTP-activated form of
Rab3A (Ozaki et al., 2000). In fact, we found that Rim2a inter-
acted with the GTP-activated form of Rab3A (Figure 4F). There-
fore, we examined the effect of the active form of Rab3A on the
interaction of Rim2a and Munc13-1. The interaction of Rim2a
and Munc13-1 in the presence of the constitutively active form
of Rab3A (Q81L) (Brondyk et al., 1993) was detected in a glucose
concentration-independent manner (Figures 4F and S2). These
results indicate that Munc13-1 dissociates from the Rim2a/
Munc13-1 complex by glucose stimulation.
Rim2a Is Critical for Docking and Priming
of Insulin Granules
The finding of differences in the interactions with these three
molecules indicates that Rim2a is involved in the recruitment,
docking, and/or priming steps. Rab3A and Munc13-1 have
been shown to interact with the N-terminal region of Rim2a
(Dulubova et al., 2005). To determine whether the impaired
insulin secretion in Rim2ako/ko b cells is caused by defective
interaction of Rim2a with Rab3A, Munc13-1, or both of them,
we prepared a double mutant (E36A/R37S) of Rim2a that cannot
bind to Rab3A but can bind to Munc13-1 (Fukuda, 2004). Using
this mutant, we examined insulin secretion and the number of
docked insulin granules in Rim2ako/ko b cells. Although the
mutant Rim2a (E36A/R37S) was able to restore both glucose-
and K+-induced insulin secretion (Figures 5A, top-left, and 6A),
the mutant Rim2a (E36A/R37S) was unable to restore the
number of docked insulin granules (Figure 5A, top-right), sug-
gesting that the interaction of Rim2a and Rab3A is required
for docking of the insulin granules, but not for fusion of the
granules to the plasma membrane. Of interest, because
K+-induced insulin secretion in Rim2ako/ko b cells was signifi-
cantly higher than that by WT Rim2a gene transfer, the interac-
tion of Rim2a and Rab3A may negatively regulate insulin
secretion (Figures 5A, top and lower-left, and 6A), that is, dock-
ing may be a state-preventing fusion (i.e., a braking state).
We then prepared a double mutant (K136E/K138E) of Rim2a
that cannot bind to Munc13-1 but can bind to Rab3A (Dulubova
et al., 2005). Although the mutant Rim2a (K136E/K138E) was
unable to restore either glucose- or K+-induced insulin secretion
(Figures 5A, top-left, and 6A), the mutant was able to restore the
number of docked insulin granules (Figure 5A, top-right). These.
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Figure 3. Rim2a-Mediated Insulin Granule Exocytosis
(A) Comparison of the number of insulin granules docked to the plasma membrane in pancreatic b cells of Rim2a+/+ and Rim2a/ mice. Primary cultured
pancreatic b cells were preincubated with HEPES-KRB buffer containing 2.8 mM glucose at 37C for 30 min, fixed, immunostained with anti-insulin antibody,
and observed by TIRFM. The surrounding lines represent the outline of a cell attached to the cover glass. The number of docked granules was measured in
a cell surface area of 200 mm2. Scale bar, 10 mm. Data were obtained from three independent experiments (n = 8) and expressed as means ± SEM. *p < 0.01
(Student’s unpaired t test).
(B) Histogram of fusion events at 30 s intervals in pancreatic b cells of Rim2a+/+ (left) and Rim2a/ (right) mice stimulated with 60 mM K+ in a cell surface area of
200 mm2. Primary cultured pancreatic b cells were preincubated with HEPES-KRB buffer containing 2.8 mM glucose at 37C for 30 min. Thirty seconds after
acquisition of the image, the primary cultured cells were stimulated with 60 mM K+; 2.8 indicates 2.8 mM glucose. Old face (blue): Granules that are predocked
to the plasma membrane and fused to the membrane by stimulation. Restless newcomer (red): Granules that are newly recruited and immediately fused to the
plasmamembrane by stimulation.Resting newcomer (green): Granules that are newly recruited, docked, and fused to the plasmamembrane by stimulation. Data
were obtained from five to six independent experiments (n = 6–7) and expressed as means ± SEM.
(C) Histogram of fusion events in pancreatic b cells of Rim2a+/+ (left) and Rim2a/ (right) mice stimulated with 25 mM glucose in a cell surface area of 200 mm2.
Fusion events were analyzed as shown in (B). Data were obtained from five to six independent experiments (n = 6–7) and expressed as means ± SEM.
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Role of Rim2a in Insulin Granule Exocytosisresults suggest that interaction of Rim2a andMunc13-1 after the
docking step is required for insulin granule exocytosis (Figures
5A, top and lower-right, and 6A).
To examine whether Rim2a enhances Munc13-1 activity in
pancreatic b cells, we evaluated insulin secretion in Rim2ako/ko
b cells by phorbol 12-myristate 13-acetate (PMA), which is
known to enhance Munc13-1 activity in pancreatic b cells
(Betz et al., 1998; Kang et al., 2006). Glucose-induced insulin
secretion was restored in Rim2ako/ko b cells in the presence of
PMA (Figures 5B, left, and 6B). However, the number of docked
insulin granules was not increased in Rim2ako/ko b cells (Fig-
ure 5B, middle). These results suggest that Rim2a directly acti-Celvates Munc13-1 and that it regulates postdocking steps of
insulin granule exocytosis (Figure 5B, right).
Activation of Munc13-1 is proposed to change Syntaxin1 from
the closed state to the open state, initiating the priming step of
granule exocytosis (Madison et al., 2005). Thus, Syntaxin1 might
not be activated inRim2ako/ko b cells. If that is the case, introduc-
tion of exogenous open Syntaxin1 into Rim2ako/ko b cells should
bypass the interaction of Rim2a and Munc13-1 to stimulate
insulin secretion directly. To investigate this possibility, we
examined insulin secretion and the number of docked insulin
granules in Rim2ako/ko b cells after gene transfer of open
Syntaxin1 (Dulubova et al., 1999). Open Syntaxin1 fully restoredl Metabolism 12, 117–129, August 4, 2010 ª2010 Elsevier Inc. 121
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Role of Rim2a in Insulin Granule Exocytosisboth glucose- and K+-induced insulin secretion, but WT Syn-
taxin1 did not restore it (Figures 5C, left, and 6C). In contrast,
both forms of Syntaxin1 were unable to restore the number of
docked insulin granules (Figure 5C, middle). These findings
indicate that interaction of Rim2a and Munc13-1 is required in
the process of exocytosis between the docking and fusion steps,
suggesting that such interaction underlies priming of insulin
granules.Rim2a Is Required for Epac2-Potentiated Insulin
Secretion
Rim2a was originally identified as a molecule that interacts
with Epac2 (Ozaki et al., 2000). Because Epac2 is responsible
for cAMP-dependent, PKA-independent exocytosis, interaction
of Rim2a and Epac2 is thought to be involved in cAMP-poten-
tiated insulin secretion (Ozaki et al., 2000; Kashima et al.,
2001). To clarify the role of Rim2a in cAMP-potentiated insulin
secretion, we utilized Rim2ako/ko b cells, preparing a triple
mutant (R682A, L688A, and G689A) (PDZ-AAA) of Rim2a that
disrupts the interaction of Rim2a and Epac2 (Shibasaki
et al., 2004). This mutant Rim2a (PDZ-AAA) significantly
rescued, although not completely, glucose-induced insulin
secretion. Importantly, the glucose-induced insulin secretion
potentiated by the Epac-specific cAMP analog 8-pCPT-20-O-
Me-cAMP-AM (Vliem et al., 2008) failed to potentiate insulin
secretion in these cells (Figure 7). These results make clear
that Rim2a mediates cAMP-induced, Epac2-dependent insulin
secretion.Rim2a Deficiency Causes Multiple Defects
in Hormone Secretion
Systemic analysis of offspring from heterozygous mating
revealed that Rim2a/ mice were smaller than littermate
Rim2a+/+ mice (Figure S1K). Both basal- and hypoglycemia-
induced GH secretion were markedly reduced in Rim2a/
mice (Figure S1L), and insulin-like growth factor-1 (IGF-1) levels
were decreased in the mice (Figure S1M). In addition, hypogly-
cemia-induced epinephrine secretion was significantly
decreased in Rim2a/ mice (Figure S1N). In contrast, hypogly-
cemia-induced glucagon secretionwas significantly increased in
Rim2a/ mice (Figure S1O), a finding consistent with the
increase in the number of a cells. Taken together, these results
show that Rim2a is required for normal regulation of hormone
secretion associated with glucose homeostasis.Figure 4. Generation and Characterization of Rim2ako/ko b Cells
(A) Immunocytochemical analysis of MIN6 cells and Rim2ako/ko b cells. Green, R
(B) Comparison of expression levels of exocytosis-related proteins among MIN6
(C) Subcellular localization of exocytosis-related proteins in Rim2ako/ko b cells. R
separated on discontinuous sucrose gradients. Fractions were subjected to im
Chromogranin-A (large dense-core granule marker), Rim2, Rab3A, Munc13-1, an
(D) Insulin secretion fromRim2ako/ko b cells. Data were obtained from three indepe
corresponding values in Ad-b-gal (Student’s unpaired t test).
(E) The number of insulin granules docked to the plasmamembrane inRim2ako/ko b
expressed as means ± SEM. *p < 0.01 versus Ad-b-gal (Student’s unpaired t tes
(F) Effect of glucose on the interaction of Rim2a and Rab3A or Munc13-1. After
25 mM glucose for 30 min, their lysates were incubated with lysates of COS-1
immunoprecipitation with anti-c-Myc antibody-conjugated agarose and then to
See also Figure S2.
CelDISCUSSION
Rim1a is a multidomain adaptor protein that was discovered as
a putative effector of Rab3 (Wang et al., 1997). The null mutation
of Rim in C. elegans was shown to decrease the number of
fusion-competent vesicles, suggesting a role in the postdocking
process (Koushika et al., 2001). We previously identified Rim2a
as a molecule interacting with Epac2 and found that it was
required for cAMP-dependent, PKA-independent insulin secre-
tion in vitro (Ozaki et al., 2000; Kashima et al., 2001). However,
the role of Rim2a in exocytosis has not been clarified. To address
this issue, we generated Rim2a/ mice. In the course of our
study, Schoch et al. reported the phenotype of Rim2a/ mice,
which they generated independently, but no changes in blood
glucose levels in Rim2a/ mice were found (Schoch et al.,
2006). In the present study, we have analyzed the phenotype
of Rim2a/ mice in detail both in vivo and in vitro.
We recently reported that K+-induced exocytosis comprises
mainly granules already docked to the plasma membrane (old
face), whereas glucose-induced exocytosis consists almost
exclusively of granules that are newly recruited to the plasma
membrane (restless newcomer) (Shibasaki et al., 2007). In the
present study, we show that a mutant Rim2a (E36A/R37S) that
does not bind to Rab3A did not rescue docked granules in
Rim2ako/ko b cells but was able to rescue glucose-induced
insulin secretion to a degree similar to that rescued by WT
Rim2a. This finding indicates that, although docking of insulin
granules to the plasma membrane requires interaction of
Rim2a and Rab3A, it is not essential for glucose-induced insulin
secretion. Indeed, despite the defect in docking, K+-induced
insulin secretion is significantly increased in granuphilin/
mice (Gomi et al., 2005).
It has been thought that the priming and fusion steps occur
after the docking step in neuronal cells (Verhage and Sørensen,
2008). The priming step is proposed to be initiated by unfolding
of the SNARE protein Syntaxin1 from the closed to the open
state, which can bind SNAP25 and VAMP2, which are other
SNARE proteins, to form the SNARE complex. The mutant
Syntaxin1 (L166A/E167A), which is a constitutively open form
(Dulubova et al., 1999), can rescue the fusion of synaptic vesicles
in C. elegans Syntaxin null mutants (Richmond et al., 2001).
Although Munc13-1 is thought to be a priming factor in large
dense-core and synaptic vesicles and the interaction of Rim1a
and Munc13-1 is thought to regulate priming (Ashery et al.,
2000; Betz et al., 2001), the molecular mechanism of the primingim2; red, Insulin. Scale bar, 5 mm.
cells, Rim2ako/ko b cells, and Rim2ako/ko b cells expressing WT Rim2a.
im2ako/ko b cells were homogenized, and organelles in the supernatants were
munoblot analysis with anti-Na+-K+-ATPase a-1 (plasma membrane marker),
d Syntaxin1.
ndent experiments (n = 7–11) and expressed asmeans ± SEM. *p < 0.01 versus
cells. Data were obtained from three independent experiments (n = 11–16) and
t). Scale bars, 5 mm.
Rim2ako/ko b cells expressing c-Myc-tagged WT Rim2a were stimulated with
cells expressing FLAG-tagged Rab3A (Q81L). Their mixture was subjected to
immunoblot analysis with anti-Rim2, Rab3A, and Munc13-1 antibodies.
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Role of Rim2a in Insulin Granule Exocytosisstep has not been clarified. In Rim1a/ brain, the expression
level of Munc13-1 is decreased (Schoch et al., 2002), and
Munc13-1 is not enriched at the active zone of mossy fiber
terminals of mouse hippocampus (Andrews-Zwilling et al.,
2006). We found that both the expression level and the localiza-
tion of Munc13-1 are not changed in Rim2ako/ko b cells but that
Munc13-1 dissociates from the Rim2a/Munc13-1 complex by
glucose stimulation and activates Syntaxin1 to evoke fusion.
Rim2a is thus a critical molecule in determining both the docking
and priming states in accord with its interacting partner Rab3A or
Munc13-1, respectively (Figure S3).
We previously showed that Rim2a is involved in cAMP-depen-
dent, PKA-independent insulin secretion through the Epac2
pathway (Ozaki et al., 2000; Kashima et al., 2001). We show
here that glucose-induced insulin secretion potentiated by
the Epac-specific analog 8-pCPT-20-O-Me-cAMP-AM is not
induced in Rim2ako/ko b cells expressing mutant Rim2a (PDZ-
AAA). This further confirms that Rim2a is required in the Epac2
pathway for potentiation of insulin secretion by cAMP. Because
Epac2 also activates Rap1 by cAMP, which may increase the
size of the nondocked granule pool and/or facilitate the recruit-
ment of granules to the plasma membrane (Shibasaki et al.,
2007; Seino et al., 2009), both Rim2a and Rap1 act cooperatively
in cAMP-induced, Epac2-dependent insulin secretion.
In this study, we also found that Rim2a exerts a suppressive
effect on the voltage dependence of inactivation of voltage-
dependent Ca2+ channel (VDCC) currents and controls the
intracellular Ca2+ concentration in pancreatic b cells (Figure S4),
as was found of Rim1a in neurons (Kiyonaka et al., 2007).
Rim2a has been shown to interact with VDCCs directly or indi-
rectly (Hibino et al., 2002; Shibasaki et al., 2004). It is generally
accepted that neuronal secretion represents vesicle fusion in
response to Ca2+ microdomains, which requires close proximity
of the vesicles to the sites of focal Ca2+ entry (Llina´s et al., 1992;
Barg et al., 2001; Hoppa et al., 2009). These findings together
with the role of Rim2a further suggest the importance of the Ca2+
microdomain for insulin granule exocytosis in pancreatic b cells.
Rim2a is expressed predominantly in endocrine and neuroendo-
crine cells (Ozaki et al., 2000). Because we found defects in the
secretion of various hormones, including GIP, GH, and epineph-
rine, all of which are stored as dense-core granules, Rim2amight
well play a similar role in exocytosis of these hormones.
EXPERIMENTAL PROCEDURES
Reagents
A full list of reagents is provided in the Supplemental Experimental Procedures.Figure 5. Rescue Experiments of Insulin Secretion and the Number of
(A) Effects ofmutant Rim2a on insulin secretion and the number of insulin granules
secretion in Rim2ako/ko b cells expressing mutant Rim2a. (Upper-left) The numb
expressing mutant Rim2a. In the absence of interaction of Rim2a and Rab3A, in
docking of insulin granules, which prevents fusion to the plasma membrane (b
but can bind to Rab3A allows the granules to dock. Because priming is not ini
corresponding values in Ad-b-gal (Dunnett’s method). yp < 0.01 versus correspo
(B) Effect of PMA stimulation on insulin secretion (left) and the number of insulin
granule exocytosis in Rim2ako/ko b cells stimulated with PMA. *p < 0.01 versus c
(C) Effect of Syntaxin1 on insulin secretion (left) and the number of insulin granul
exocytosis in Rim2ako/ko b cells expressing open Syntaxin1. *p < 0.01 versus co
Data were obtained from three independent experiments (n = 7–11) and express
See also Figure S3.
CelGeneration of Rim2a/ Mice
Rim2a/mice were generated by replacing the amino acid coding sequences
in exon 4 of mouse Rim2 with Neo cassette as described (Figure S1). Detailed
description and genotyping strategy are provided in Supplemental Experi-
mental Procedures.
Generation of Rim2a-Deficient Clonal Pancreatic b Cells
Clonal pancreatic b cells lacking Rim2a (Rim2ako/ko b cells) were established
by crossbreeding Rim2a/ mice and IT6 mice expressing SV40 large T
antigen under human insulin promoter that developed highly differentiated
b cell tumors (Miyazaki et al., 1990). Twenty-seven lines of Rim2ako/ko b cells
were generated from a 10-week-old mouse lacking Rim2a and carrying a
large T antigen load (Rim2a/; IT6mouse) as previously described (Shibasaki
et al., 2007).
Cell Culture
MIN6 cells, Rim2ako/ko b cells, and COS-1 cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% heat-inactivated fetal
bovine serum and maintained in a humidified incubator with 95% air and 5%
CO2 at 37
C.
RNA Extraction and Quantitative RT-PCR
Total RNA from mouse pancreatic islets and b cell lines was isolated using
the RNeasy Kit. For reverse transcription, ReverTra Ace-a-Kit was used.
Quantitative real-time PCR was carried out by SYBR Premix Ex Taq with the
primers for mouse Rim2a (forward 50-GGAAAATCATCCTGGCTGTC and
reverse 50-ATGTCACTGGCAATCTGGTG), mouse Rim2b (forward 50-ACGA
AGTCCATCAGTGTCCA and reverse 50-GCTCAGACCATTCCAAATCC), and
HPRT (forward 50-TCTTTGCTGACCTGCTGGATT and reverse 50-GGCTT
TGTATTTGGCTTTTCC) using a model 7000 thermal cycler (Applied Biosys-
tems, Foster City, CA). HPRT was used as internal control (Figure S1).
In Vivo Experiments
Glucose (1.5 g/kg body weight), mixed meal (Twinline: 10 ml/kg body weight),
or insulin (0.4 IU/kg body weight) was administered intraperitoneally or orally
to overnight (16 hr) fasted male mice at 16–22 weeks of age as described
previously (Miki et al., 2005). Blood glucose levels weremeasured by Antsense
III glucose analyzer (Bayer Yakuhin, Osaka, Japan); ELISA system was used
for measurement of serum insulin (Morinaga, Tokyo, Japan), GIP and GH
(LINCO Research, St. Charles, MO), and IGF-1 (R&D Systems, Minneapolis,
MN). Measurements of epinephrine levels were performed by SRL
(Tokyo, Japan).
Immunohistological Analysis
The pancreases were removed from Rim2a+/+ and Rim2a/ mice and were
immersion fixed in 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4). Fixed tissues were dehydrated and embedded in paraffin by conven-
tional procedure. Five-micrometer-thick paraffin sections were stained with
guinea pig anti-insulin antibody and mouse anti-glucagon antibody, followed
by Alexa Fluor 546-conjugated goat anti-guinea pig IgG antibody and
Alexa Fluor 488-conjugated goat anti-mouse IgG antibody, respectively. The
immunostained tissues were observed by BZ9000 microscope (Keyence,
Osaka, Japan).Docked Insulin Granules in Rim2ako/ko b Cells
docked to the plasmamembrane. (Upper-left) Glucose- and K+-induced insulin
er of insulin granules docked to the plasma membrane in Rim2ako/ko b cells
sulin granule exocytosis is rather enhanced because the interaction induces
raking) (lower-left). In contrast, mutant Rim2a that cannot bind to Munc13-1
tiated in this state, fusion events do not occur (lower-right). *p < 0.01 versus
nding values in Ad-WT Rim2a (Tukey-Kramer method).
granules docked to the plasma membrane (middle). (Right) Model for insulin
orresponding values in the absence of PMA (Student’s unpaired t test).
es docked to the plasma membrane (middle). (Right) Model for insulin granule
rresponding values in Ad-b-gal (Dunnett’s method).
ed as means ± SEM. Red, Rim2a; blue, Rab3A; green, Munc13-1.
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Figure 7. Effect of the Triple-Mutant Rim2a on Epac2-Mediated
Exocytosis
Rim2ako/ko b cells expressing Rim2a (PDZ-AAA) were stimulated with 11.1 mM
glucose plus 10 mM 8-pCPT-20-O-Me-cAMP-AM. Data were obtained from
three independent experiments (n = 8–11) and expressed as means ± SEM.
*p < 0.01 (Dunnett’s method).
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Role of Rim2a in Insulin Granule ExocytosisImmunocytochemical Analysis
MIN6 cells and Rim2ako/ko b cells were fixed with 3.7% formaldehyde in 0.1 M
phosphate buffer (pH7.4) for 10min at room temperature and thoroughly rinsed
with 0.1M PBS. After the samples were pretreated with 0.1% Triton X-100 and
10% normal goat serum, they were incubated with guinea pig anti-insulin anti-
body and rabbit anti-Rim2 antibody, followed by Alexa Fluor 546-conjugated
goat anti-guinea pig IgG antibody and Alexa Fluor 488-conjugated goat anti-
rabbit IgG antibody, respectively. The immunostained cells were observed by
confocal laser scanning microscopy (FV1000; Olympus, Tokyo, Japan).
Insulin Secretion Experiments
Pancreatic islets were isolated from Rim2a+/+ and Rim2a/ mice by collage-
nase digestion and cultured for 2 days as described previously (Kashima et al.,
2001). Thirty minutes after preincubation of isolated islets with HEPES-KRB
buffer containing 2.8 mM glucose, five size-matched islets were collected in
each well of a 96-well plate and incubated for 30 min in 100 ml of the same
buffer containing various stimuli. Insulin released in the incubation buffer and
cellular insulin content were measured by ELISA (Medical Biological Laborato-
ries, Nagoya, Japan). The amount of insulin secretion was normalized
by cellular insulin content. Insulin secretion experiments in MIN6 cells and
Rim2ako/ko b cells were performed as described above.
TIRFM Analysis
Primary cultured b cells isolated from mouse pancreatic islets were infected
with adenovirus carrying insulin-Venus and subjected to analysis by TIRFM
as previously described (Shibasaki et al., 2007). The number of granules
docked to the plasma membrane was measured by G-Count software
(G-Angstrom K.K, Miyagi, Japan).
Subcellular Fractionation
Discontinuous sucrose gradient fractionation of MIN6 cells and Rim2ako/ko
b cells were carried out as previously described (Sugawara et al., 2009).Figure 6. Insulin Secretion from Perifused Rim2ako/ko b Cells
(A) Effects of mutant Rim2a on insulin secretion. In the absence of interaction of Ri
WT Rim2a gene transfer. In contrast, mutant Rim2a that cannot bind to Munc13
(B) Effect of PMA stimulation on insulin secretion. Insulin secretion is induced by
(C) Effect of Syntaxin1 on insulin secretion induced by glucose (left) and K+ (righ
Data were obtained from two to three independent experiments (n = 4–5) and ex
See also Figure S4.
CelCoimmunoprecipitation Experiments
Two days before coimmunoprecipitation experiments, COS-1 cells were
transiently transfected with plasmids encoding FLAG-tagged Rab3A (Q81L)
using Effectene Transfection Reagent (QIAGEN) according to the manufac-
turer’s instruction. Coimmunoprecipitation experiments were performed using
PierceMammalian c-Myc Tag IP/Co-IP Kit (Thermo Fisher Scientific,Waltham,
MA) according to the manufacturer’s instruction. In brief, Rim2ako/ko b cells
were infected with Ad-b-galactosidase (b-gal) or Ad-Rim2a. After 2 day
culture, the infected cells were preincubated in HEPES-KRB buffer containing
2.8 mM glucose. Thirty minutes after preincubation, the cells were stimulated
with HEPES-KRB buffer containing 2.8 mM glucose or 25 mM glucose for
30 min. The cells were then lysed in buffer containing 10 mM HEPES
(pH 7.4), 150 mM NaCl, 0.5% CHAPS, 5 mM MgCl2, and protease inhibitor
cocktail and were collected in microcentrifuge tubes. The cellular lysates
were incubated with 10 ml anti-c-Myc antibody conjugated with agarose
in the absence or presence of cellular lysate of COS-1 transfected with
FLAG-tagged Rab3A (Q81L). After incubation at 4C for overnight, the agarose
was washed five times with buffer containing 25 mM Tris-HCl, 150 mM NaCl,
and 0.05% Tween 20 (pH 7.2), and the bound proteins were subjected to
SDS-PAGE followed by immunoblot analysis with anti-Rim2, anti-Munc13,
and anti-Rab3 antibodies.Construction of Adenovirus Vectors
Rat Rab3A was subcloned into pFLAG-CMV-2 vector (Sigma). Site-directed
mutagenesis of the N-terminal Zn2+-finger domain (E36A/R37S and
K136E/K138E mutants) and PDZ domain (PDZ-AAA mutant) in mouse Rim2a
and L166A/E167A mutant in mouse Syntaxin1 was performed by the
PCR-based method. Recombinant adenovirus carrying c-Myc-tagged WT
Rim2a (Ad-Rim2a) or c-Myc-tagged mutants of Rim2a (Ad-Rim2a mutants)
were generated according to the manufacturer’s instruction (Stratagene,
La Jolla, CA).Perifusion Experiments
Perifusion experiments on insulin secretion of Rim2ako/ko b cells were
performed as described previously (Sugawara et al., 2009). In brief, the cells
were seeded at a density of 5 3 105 cells on coverslips. The following day,
the cells were infected with Ad-b-gal or Ad-Rim2a mutants or Ad-Syntaxin1
at an MOI of 1 and maintained for 48 hr. The cells were then incubated in
HEPES-KRB containing 2.8 mM glucose for 50min andmounted in a perifusion
chamber. The cells were perifused in KRBH containing 2.8 mM glucose for
5 min, and the perfusate was then switched to HEPES-KRB containing
25mM glucose or 60mMK+. Eluted fractions were collected at 1min intervals,
and released insulin in each fraction wasmeasured by insulin assay kit (CIS bio
international, Gif sur Yvette, France). The amount of secreted insulin was
normalized by cellular insulin contents.Statistical Analysis
The data are expressed as means ± SEM. Comparisons were made using
Student’s unpaired t test, Dunnet’s method, or Tukey-Kramer’s method as
indicated in the legends. A probability level of p < 0.05 was considered
statistically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.cmet.2010.05.017.m2a and Rab3A, K+-induced insulin secretion is enhanced compared to that by
-1 does not restore either glucose- or K+-induced insulin secretion.
PMA even in the absence of Rim2a.
t). Open Syntaxin1 rescues both glucose- and K+-induced insulin secretion.
pressed as means ± SEM.
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